Health ❯ Healthcare ❯ Mental Health

Depression

Anxiety Treatment Options Antidepressants Major Depressive Disorder Symptoms Support Systems Treatment Adolescents Therapy Treatment Outcomes

3 ARTICLES

last wk.

Real‑World Data Show Fezolinetant Cuts Hot Flashes and Eases Mood Symptoms

Industry‑sponsored observational results indicate the drug’s clinical‑trial benefits appear in a broader patient group but do not prove cause and effect.

8 ARTICLES

last mo.

Moraes Authorizes Supervised Cranial Stimulation Treatments for Bolsonaro in Custody

3 ARTICLES

4mo ago

Perceptive Advisors Makes Praxis Its Largest Holding After Disclosing Big Q4 Buy

3 ARTICLES

5mo ago

NHS Reminds Sertraline Users to Avoid Grapefruit

8 ARTICLES

6mo ago

Dorismar Alleges Disfigurement From Botched Rhinoplasties, Begins Reconstructive Surgery in Bogotá

3 ARTICLES

6mo ago

One in Four French Mothers Report Disrespectful Maternity Care, Linked to Higher Postpartum Depression

4 ARTICLES

6mo ago

German Study Finds About One-Third of Dementia Cases Are Potentially Preventable

5 ARTICLES

7mo ago

Kessler Twins’ Assisted Deaths Followed Long Planning, Friend Says

6 ARTICLES

7mo ago

FDA Approves Darzalex Faspro as First Therapy for High-Risk Smoldering Multiple Myeloma

9 ARTICLES

8mo ago

Lancet Analysis Finds Marked Short‑Term Differences in Antidepressants’ Effects on Weight and Heart Health

14 ARTICLES

8mo ago

The Lancet Review Finds Antidepressants Differ Sharply in Weight, Heart Rate and Blood Pressure Effects

8 ARTICLES

9mo ago

UK Psychiatrists Endorse Ketamine for Depression in Specialist Care

4 ARTICLES

10mo ago

Hearing Aids Before 70 Tied to Sharply Lower Dementia Risk, JAMA Neurology Study Finds

4 ARTICLES

10mo ago

Cochrane Review Finds No Clear Benefit for Ketamine in Chronic Pain

3 ARTICLES

11mo ago

Older Surgery Patients Face Doubled Stays and Costs, Surgeons Urged to Add Palliative Care

Depression

Real‑World Data Show Fezolinetant Cuts Hot Flashes and Eases Mood Symptoms

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

Mental Disorders Lead 2024 Hospital Stays for German Teens

Antidepressant Fluvoxamine Eases Long COVID Fatigue in Randomized Trial

BullFrog AI Strikes Top-5 Pharma Deal To Find Depression Drug Targets

Canada Issues Integrated Brain–Heart Care Guideline With 11 Recommendations

Moraes Authorizes Supervised Cranial Stimulation Treatments for Bolsonaro in Custody

Perceptive Advisors Makes Praxis Its Largest Holding After Disclosing Big Q4 Buy

NHS Reminds Sertraline Users to Avoid Grapefruit

Dorismar Alleges Disfigurement From Botched Rhinoplasties, Begins Reconstructive Surgery in Bogotá

Never miss stories about

Depression

One in Four French Mothers Report Disrespectful Maternity Care, Linked to Higher Postpartum Depression

German Study Finds About One-Third of Dementia Cases Are Potentially Preventable

Kessler Twins’ Assisted Deaths Followed Long Planning, Friend Says

FDA Approves Darzalex Faspro as First Therapy for High-Risk Smoldering Multiple Myeloma

Lancet Analysis Finds Marked Short‑Term Differences in Antidepressants’ Effects on Weight and Heart Health

The Lancet Review Finds Antidepressants Differ Sharply in Weight, Heart Rate and Blood Pressure Effects

UK Psychiatrists Endorse Ketamine for Depression in Specialist Care

Hearing Aids Before 70 Tied to Sharply Lower Dementia Risk, JAMA Neurology Study Finds

Cochrane Review Finds No Clear Benefit for Ketamine in Chronic Pain

Older Surgery Patients Face Doubled Stays and Costs, Surgeons Urged to Add Palliative Care

Never miss stories about

Depression